Basket | Login | Register

 
 
 
 

GAIN (coming soon)

Phase III trials

Study Information

Name of the study

GAIN Trial: A Randomized, Double-Blind, Placebo-Controlled Study of COR388 in Subjects with Alzheimer's disease

Study sponsor

Cortexyme

Disease

Subjects with a clinical diagnosis of mild to moderate Alzheimer's disease dementia

Phase

Phase II/III

Information about the drug that will be tested in the study

Name of drug

COR388

Where and when will the study be conducted?

European countries involved in the trial

Poland

Estimated start date of recruitment

September 2019

Information for your doctor

Clinicaltrials.gov identifier

NCT03823404

Study contact information

clincaltrials@cortexyme.com

Link to full text

https://clinicaltrials.gov/ct2/show/study/NCT03823404

An accessible easy read information on the GAIN study will be available soon.

 

 
 

Last Updated: Friday 27 September 2019

 

 
 

Options